» Articles » PMID: 30219861

A Synthetic Free Fatty Acid-regulated Transgene Switch in Mammalian Cells and Mice

Overview
Specialty Biochemistry
Date 2018 Sep 17
PMID 30219861
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Trigger-inducible transgene expression systems are utilized in biopharmaceutical manufacturing and also to enable controlled release of therapeutic agents in vivo. We considered that free fatty acids (FFAs), which are dietary components, signaling molecules and important biomarkers, would be attractive candidates as triggers for novel transgene switches with many potential applications, e.g. in future gene- and cell-based therapies. To develop such a switch, we rewired the signal pathway of human G-protein coupled receptor 40 to a chimeric promoter triggering gene expression through an increase of intracellular calcium concentration. This synthetic gene switch is responsive to physiologically relevant FFA concentrations in different mammalian cell types grown in culture or in a bioreactor, or implanted into mice. Animal recipients of microencapsulated sensor cells containing this switch exhibited significant transgene induction following consumption of dietary fat (such as Swiss cheese) or under hyperlipidaemic conditions, including obesity, diabetes and lipodystrophy.

Citing Articles

Synthetic Gene Circuits for Regulation of Next-Generation Cell-Based Therapeutics.

Teixeira A, Fussenegger M Adv Sci (Weinh). 2023; 11(8):e2309088.

PMID: 38126677 PMC: 10885662. DOI: 10.1002/advs.202309088.


Molecular Drug Simulation and Experimental Validation of the CD36 Receptor Competitively Binding to Long-Chain Fatty Acids by 7-Ketocholesteryl-9-carboxynonanoate.

Fu C, Xiang M, Chen S, Dong G, Liu Z, Chen C ACS Omega. 2023; 8(31):28277-28289.

PMID: 37576668 PMC: 10413453. DOI: 10.1021/acsomega.3c02082.


Engineering natural molecule-triggered genetic control systems for tunable gene- and cell-based therapies.

Wang X, Zhou X, Kang L, Lai Y, Ye H Synth Syst Biotechnol. 2023; 8(3):416-426.

PMID: 37384125 PMC: 10293594. DOI: 10.1016/j.synbio.2023.06.002.


Biomarker-driven feedback control of synthetic biology systems for next-generation personalized medicine.

Stefanov B, Fussenegger M Front Bioeng Biotechnol. 2022; 10:986210.

PMID: 36225597 PMC: 9548536. DOI: 10.3389/fbioe.2022.986210.


Synthetic biology as driver for the biologization of materials sciences.

Burgos-Morales O, Gueye M, Lacombe L, Nowak C, Schmachtenberg R, Horner M Mater Today Bio. 2021; 11:100115.

PMID: 34195591 PMC: 8237365. DOI: 10.1016/j.mtbio.2021.100115.


References
1.
Tobin A, Butcher A, Kong K . Location, location, location...site-specific GPCR phosphorylation offers a mechanism for cell-type-specific signalling. Trends Pharmacol Sci. 2008; 29(8):413-20. PMC: 2880250. DOI: 10.1016/j.tips.2008.05.006. View

2.
Palli S, Kapitskaya M, Potter D . The influence of heterodimer partner ultraspiracle/retinoid X receptor on the function of ecdysone receptor. FEBS J. 2005; 272(23):5979-90. DOI: 10.1111/j.1742-4658.2005.05003.x. View

3.
Maltoni M, Nanni O, Scarpi E, Rossi D, Serra P, Amadori D . High-dose progestins for the treatment of cancer anorexia-cachexia syndrome: a systematic review of randomised clinical trials. Ann Oncol. 2001; 12(3):289-300. DOI: 10.1023/a:1011156811739. View

4.
Kemmer C, Gitzinger M, Daoud-El Baba M, Djonov V, Stelling J, Fussenegger M . Self-sufficient control of urate homeostasis in mice by a synthetic circuit. Nat Biotechnol. 2010; 28(4):355-60. DOI: 10.1038/nbt.1617. View

5.
Briscoe C, Tadayyon M, Andrews J, Benson W, Chambers J, Eilert M . The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. J Biol Chem. 2002; 278(13):11303-11. DOI: 10.1074/jbc.M211495200. View